Business
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
Partnership results in over 275 physicians recommending VIVI Cap to patients, strengthening clinical validation and driving scalable patient education and acquisitionVancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that more than 275 physicians across the United States
About this update from Tempramed Technologies Ltd.
[{"type":"text","content":"Partnership results in over 275 physicians recommending VIVI Cap to patients, strengthening clinical validation and driving scalable patient education and acquisition","length":166,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that more than 275 physicians across the United States have recommended and included VIVI Cap in the offers available to their patients across FrontrowMD, a leading physician engagement and education platform.","length":509,"tagName":"p"},{"type":"text","content":"The Company's partnership with FrontrowMD and the subsequent positive reception from physicians across the United States represents another significant milestone in TempraMed's commercialization strategy, validating strong physician demand for practical, real-world solutions that protect temperature-sensitive medications beyond the pharmacy and clinic setting.","length":370,"tagName":"p"},{"type":"text","content":"Partnership Highlights","length":22,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"FrontrowMD, is a trusted platform enabling physician-led product education and patient recommendation","length":101,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Over 275 physicians are sharing VIVI Cap to patients across multiple therapeutic areas and growing","length":98,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The physician-driven adoption model strengthens trust, compliance, and patient engagement","length":89,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Scalable channel supports sustained B2C demand generation through clinical endorsement","length":86,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"TempraMed's positioning as a standard-of-care adjunct for temperature-sensitive medications is reinforced","length":109,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":483,"olType":false},{"type":"text","content":""Physician recommendations are the most powerful drivers of p...